AMP Capital Investors Ltd - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMP Capital Investors Ltd ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$758,000
-50.1%
42,307
-3.4%
0.00%
-50.0%
Q2 2019$1,520,000
-6.8%
43,807
-12.2%
0.01%
-11.1%
Q1 2019$1,631,000
-5.0%
49,893
-2.2%
0.01%
-18.2%
Q4 2018$1,716,000
-63.2%
51,022
-33.3%
0.01%
-56.0%
Q3 2018$4,659,000
+164.3%
76,482
+111.8%
0.02%
+150.0%
Q2 2018$1,763,00036,1150.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders